Кардиогенный шок: обновление

Кардиогенный шок - критическое состояние, характеризующееся молниеносным развитием полиорганной недостаточности в условиях отсутствия интенсивной терапии. В статье описаны современные представления о направлениях патофизиологии, современные подходы к интенсивной терапии, рассматривается концепция «фазности» терапии, а также рассматриваются способы механической поддержки кровообращения и предлагается рабочий алгоритм выбора оптимального метода.

1. Hochman J.S., Sleeper L.A., Webb J.G., Sanborn T.A., SHOCK Investigators. Should We Emergently Revascularize White H.D., Talley J.D. et al. Early revascularization in acute Occluded Coronaries for cardiogenic shock. N Engl J Med myocardial infarction complicated by cardiogenic shock. 1999; 341:625-34. doi: 10.1056/NEJM199908263410901

2. Thiele H., Zeymer U., Neumann F.-J., e Ferenc M., Olbrich H.G., Hausleiter J.,e t al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 2012; 367:1287-96. doi: 10.1056/NEJMoa1208410.

3. Ponikowski P., Voors A.A., Anker S.D., Bueno H., Cleland J.G.F., Coats A.J.S. et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2016; 37:2129-22. doi: 10.1093/eurheartj/ehw128.

4. Baran D.A., Grines C.L., Bailey S., Burkhoff D., Hall S.A., Henry T.D. et al. SCAI clinical expert consensus statement on the classification of cardiogenic shock. Catheter Cardiovasc Interv. 2019; 94: 29-37. doi: 10.1002/ccd.28329.

5. Sean van Diepen, Holger Thiele. (2019) An overview of international cardiogenic shock guidelines and application in clinical practice. Current Opinion in Critical Care. 2019; 25:4, 365-370. doi: 10.1097/MCC.0000000000000624.

6. Jones T.L., Nakamura K., McCabe J.M. Cardiogenic shock: evolving definitions and future directions in management. Open Heart 2019; 6: e000960. doi: 10.1136/openhrt-2018-000960

7. Hochman J.S. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation. 2003; 107:2998-3002. doi:10.1161/01.CIR.0000075927.67673.F2.

8. Hoste E.A., Maitland K., Brudney C.S., Mehta R., Vincent J.-L., Yates D., Kellum J.A., Mythen M.G., Shaw A.D. for the ADQI XII Investigators Group. Four phases of intravenous fluid therapy: a conceptual model. British Journal of Anaesthesia. 2014; 113 (5): 740-747 (2014). doi:10.1093/bja/aeu300

9. Hajjar L.A., Teboul J.-L.. Mechanical Circulatory Support Devices for Cardiogenic Shock: State of the Art. Critical Care (2019) 23:76. doi: 10.1186/s13054-019-2368-y.

10. Price S., Platz E., Cullen L., Tavazzi G., Christ M., Cowie M.R. et al. Expert consensus document: echocardiography and lung ultrasonography for the assessment and management of acute heart failure. Nat Rev Cardiol. 2017; 14:427-40. doi: 10.1038/nrcardio.2017.56.

11. Jozwiak M., Monnet X., Teboul J.L. Less or more hemodynamic monitoring in critically ill patients. Curr Opin Crit Care. 2018; 24:309-15. doi: 10.1097/MCC.0000000000000516.

12. McLean A.S. Echocardiography in shock management. Critical Care201620:275. doi:10.1186/s13054-016-1401-7

13. Toscani L., Aya H.D., Antonakaki D., Bastoni D., Watson X., Arulkumaran N., Rhodes A., Cecconi M. What is the impact of the fluid challenge technique on diagnosis of fluid responsiveness? A systematic review and meta-analysis. Crit Care. 2017; 21:207. doi: 10.1186/s13054-017-1796-9

14. Levy B., Perez P., Perny J., Thivilier C., Gerard A. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study. Crit Care Med. 2011;450-455(48):39. doi: 10.1097/CCM.0b013e3181ffe0eb.

15. Tarvasmaki T., Lassus J., Varpula M., Sionis A., Sund R. , K0ber L. et al. Current real-life use of vasopressors and inotropes in cardiogenic shock—adrenaline use is associated with excess organ injury and mortality. Crit Care. 2016; 20:208. doi: 10.1186/s13054-016-1387-1.

16. Leopold V, Gayat E., Pirracchio R., Spinar J., Parenica J. , Tarvasmaki T. et al. Epinephrine and short-term survival in cardiogenic shock: an individual data meta-analysis of 2583 patients. Intensive Care Med. 2018; 44:847-56. doi: 10.1007/s00134-018-5222-9.

17. Herpain A., Bouchez S., Girardis M., Guarracino F., Knotzer J., Levy B., Liebregts T., Pollesello P, Ricksten S. E., Riha H., Rudiger A., Sangalli F. Use of Levosimendan in Intensive Care Unit Settings. An Opinion Paper. Journal of Cardiovascular Pharmacology. 2019; 73(1): 3-14. doi: 10.1097/FJC.0000000000000636

18. Vallabhajosyula S., Dunlay S.M., Prasad A., Kashani K. , Sakhuja A., Gersh B.J., Jaffe A.S., Holmes D.R., Barsness G.W. Acute Noncardiac Organ Failure in Acute Myocardial Infarction With Cardiogenic Shock. Journal of the American College of Cardiology Apr 2019, 73 (14) 1781-1791; doi: 10.1016/j.jacc.2019.01.053

19. Goldberg R.J., Makam R.C., Yarzebski J., McManus D.D., Lessard D., Gore J.M. Decade-long trends (2001-2011) in the incidence and hospital death rates associated with the in-hospital development of cardiogenic shock after acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2016; 9:117-125. doi: 10.1161/CIRCOUTCOMES.115.002359.

20. Hochman J.S., Sleeper L.A., Webb J.G., Dzavik .V, Buller C.E., Aylward P., Col J., White H.D.; SHOCK Investigators. Early revascularization and long term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 2006; 295:2511-5. doi: 10.1001/jama.295.21.2511

21. O’Gara PT., Kushner F.G., Ascheim D.D., Casey D.E. Jr, Chung M.K., de Lemos J. et al. 2013 ACCF/AHA guideline for the management of ST elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 127: e362-425. doi: 10.1161/CIR.0b013e3182742cf6.

22. Pancholy S.B., Palamaner Subash Shantha G., Romagnoli E., Kedev S., Bernat I., Rao S.V., Jolly S., Bertrand O.F., Patel T.M. Impact of access site choice on outcomes of patients with cardiogenic shock undergoing percutaneous coronary intervention: a systematic review and meta-analysis. Am Heart J. 2015; 170:353-361. doi: 10.1016/j.ahj.2015.05.001

23. Seto A.H., Roberts J.S., Abu-Fadel M.S., Czak S.J., Latif F., Jain S.P., Raza J.A., Mangla A., Panagopoulos G., Patel P.M., Kern M.J., Lasic Z. Real-time ultrasound guidance facilitates transradial access: RAUST (Radial Artery access with Ultrasound Trial). JACC Cardiovasc Interv. 2015; 8:283291. doi: 10.1016/j.jcin.2014.05.036

24. Levine G.N., Bates E.R., Blankenship J.C., Bailey S.R., Bittl J.A., Cercek B., et al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/ AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2016; 133:11351147. doi: 10.1161/CIR.0000000000000336

25. Ledwoch J., Fuernau G., Desch S., Eitel I., Jung C., de Waha S., Poss J., Schneider S., Schuler G., Werdan K., Zeymer U., Theile H.T. Drug-eluting stents versus bare-metal stents in acute myocardial infarction with cardiogenic shock. Heart. 2017 Aug;103(15):1177-1184. doi: 10.1136/heartjnl-2016-310403

26. Park J.S., Cha K.S., Lee D.S., Shin D., Lee H.W., Oh J. H., Kim J.S., Choi J.H., Park Y.H., Lee H.C., Kim J.H., Chun K. J., Hong T.J., Jeong M.H., Ahn Y, Chae S.C., Kim Y.J.; Korean Acute Myocardial Infarction Registry Investigators. Culprit or multivessel revascularization in ST-elevation myocardial infarction with cardiogenic shock. Heart. 2015; 101:1225-1232. doi: 10.1136/heartjnl-2014-307220

27. Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology (ESC), Steg P.G., James S.K., Atar D., Badano L. P., Blomstrom-Lundqvist C., Borger M.A., Di Mario C., Dickstein K., Ducrocq G., Fernandez-Aviles F., Gershlick A.H., Giannuzzi P., Halvorsen S., Huber K., Juni P., Kastrati A., Knuuti J., Lenzen M.J., Mahaffey K.W., Valgimigli M., Widimsky P., Zahger D.. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012; 33:2569-619

28. Holger Thiele, Ibrahim Akin, Marcus Sandri, Suzanne de Waha-Thiele, Roza Meyer-Saraei, Georg Fuernau, Ingo Eitel, Peter Nordbeck, Tobias Geisler, Ulf Landmesser, Carsten Skurk, Andreas Fach, et al., CULPRIT-SHOCK Investigators. One-Year Outcomes after PCI Strategies in Cardiogenic Shock. N Engl J Med 2018; 379:1699-1710 doi: 10.1056/NEJMoa1808788

29. Mehta R.H., Lopes R.D., Ballotta A., Frigiola A., Sketch M.H. Jr, Bossone E., Bates E.R. Percutaneous coronary intervention or coronary artery bypass surgery for cardiogenic shock and multivessel coronary artery disease? Am Heart J 2010; 159:141-7; doi: 10.1016/j.ahj.2009.10.035.

30. Aso S., Matsui H., Fushimi K., Yasunaga H. The effect of intraaortic balloon pumping under venoarterial extracorporeal membrane oxygenation on mortality of cardiogenic patients: an analysis using a nationwide inpatient database. Crit Care Med. 2016;44:1974-9. doi: 10.1097/CCM.0000000000001828

31. Бугаенко Д.В., Фоминых М.В., Еременко А. А. Современные устройства поддержки левого желудочка, устанавливаемые посредством чрескожного доступа. Кардиология и сердечно-сосудистая хирургия. 2018;11 (3):35-40. https://doi.org/10.17116/kardio201811335

32. Kar B., Gregoric I.D., Basra S.S., Idelchik G.M., Loyalka P. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol. 2011; 57:68896. doi: 10.1016/j.jacc.2010.08.613.

33. Ouweneel D.M., Eriksen E., Sjauw K.D., van Dongen I.M., Hirsch A., Packer E.J. et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol. 2017; 69:278-87. doi: 10.1016/j.jacc.2016.10.022.

34. Ouweneel D.M., Schotborogh J.V, Limpens J., Sjauw K.D., Engstrom A.E., Lagrand W.K. et al. Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and metaanalysis. Intensive Care Med. 2016; 42:1922-34. doi: 10.1007/s00134-016-4536-8.

35. Верещагин И.Е., Ганюков В.И., Шукевич Д.Л., Корнелюк Р.А. Первичное чрескожное коронарное вмешательство у пациента с кардиогенным шоком при поддержке экстракорпоральной мембранной оксигенации. Эндоваскулярная хирургия. 2017. Т. 4. № 3. С. 225-231.

36. Rihal C.S., Naidu S.S., Givertz M.M., Szeto W.Y., Burke J.A., Kapur N.K., Kern M., Garratt K.N., Goldstein J.A., Dimas V., Tu T.; Society for Cardiovascular Angiography and Interventions (SCAI); Heart Failure Society of America (HFSA); Society of Thoracic Surgeons (STS); American Heart Association (AHA), and American College of Cardiology (ACC). 2015SCAI/ACC/HF S A/ST S Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care: Endorsed by the American Heart Assocation, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion; Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d'intervention. J Am Coll Cardiol. 2015 May 19;65(19):e7-e26. doi: 10.1016/j.jacc.2015.03.036.

37. Корнелюк Р.А., Верещагин И.Е., Шукевич Д.Л., Ганюков В.И. Механическая поддержка кровообращения при чрескожном коронарном вмешательстве высокого риска. Комплексные проблемы сердечно-сосудистых заболеваний. 2018;7(4S):54-65. https://doi.org/10.17802/2306-1278-2018-7-4S-54-65